Diversity And Inclusion

In this episode, host Shikha Jain, MD, speaks with Kimberly Richardson about driving changes in patient advocacy efforts, the importance of including DEI in cancer research and clinical trials and more.

Fair representation of patients with skin of color in melasma trials has signaled a trend toward inclusivity in dermatology, setting a precedent for other indications, according to a study.

In this episode, host Shikha Jain, MD, speaks with ASH president, Belinda Avalos, MD, about the importance of DEI practices in medicine, leading molecular medicine developments and more.

Latinas in the U.S. medical system experience disproportionate barriers and discriminatory behaviors from colleagues and patients, according to results of an online survey.

The FDA announced its draft guidance on recommendations for studies assessing pulse oximeters to ensure the devices perform similarly in individuals with different skin pigments, according to a press release.

Following the FDA’s release of a guidance requesting more diversity in pulse oximeter testing, the number of clearance summary documents discussing race and ethnicity/skin tone rose, according to a research letter published in JAMA.

A 2020 McKinsey survey showed 84% of respondents have experienced workplace microaggressions, with additional challenges reported among women, individuals from historically underrepresented groups and members of the LGBTQ+ community.

Increased engagement in patients’ health-related social needs appeared associated with an increased likelihood for burnout among a cohort of physicians, according to a study.

Women in oncology continued to break barriers, unveil new research and accomplish major goals in 2024.

Data showed a lower likelihood for women as first and last authors of oncology clinical trials in industry-sponsored and high impact journals, according to study results presented at ASH Annual Meeting and Exposition.